WEREWOLF THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.07 USD | -0.16% |
|
-10.07% | +57.25% |
Chart calendar Werewolf Therapeutics, Inc.
50dcc5.5TCwjosssDdbcmIboelRfjL0LV3AMU_tBYhCm-q5UA8.jELe6ft9h2cWPVFv0640DnGOcg-KBh-1NbA7-oHRZXW6Vtb7un33Dz80Vg~56f0efb405a59ffdfb0ef95f3385dedd
Upcoming events on Werewolf Therapeutics, Inc.
Past events on Werewolf Therapeutics, Inc.
| 03/05/2024 04:30 pm | Q1 2024 Earnings Release |
| 09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Abstract No - 4078 |
| 09/04/2024 09:30 pm | American Association for Cancer Research Meeting - Abstract No - 4074 |
| 13/03/2024 06:50 pm | Leerink Partners Global Biopharma Conference - Fireside Chat |
| 07/03/2024 05:30 pm | Q4 2023 Earnings Release |
| 29/11/2023 06:50 pm | Evercore ISI HealthCONx Conference - Fireside Chat |
| 15/11/2023 02:55 am | Q3 2023 Earnings Release |
| 04/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1058 |
| 04/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 252 |
| 04/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1074 |
| 03/11/2023 06:00 pm | Society for Immunotherapy of Cancer Meeting |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1075 |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 1059 |
| 03/11/2023 | Society for Immunotherapy of Cancer Meeting - Abstract Number: 737 |
| 28/09/2023 01:05 am | Cantor Global Healthcare Conference |
| 18/09/2023 07:30 pm | R&D Day |
| 11/09/2023 10:00 pm | H.C. Wainwright Global Investment Conference |
| 10/08/2023 04:40 pm | Q2 2023 Earnings Release |
| 21/06/2023 06:30 pm | Annual General Meeting |
| 09/06/2023 01:30 am | Jefferies Global Healthcare Conference |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 16,4 12,0 37.12% | 19,9 20,4 -2.05% | 5,83 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -49,9 -46,8 -6.6% | -55,0 -53,2 -3.32% | -38,7 -44,7 13.34% | -69,3 |
|
EBIT Million USD | Released Forecast Spread | -22,4 | -50,1 -47,4 -5.6% | -56,1 -59,1 5.13% | -40,5 -43,3 6.38% | -62,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -50,0 -48,3 -3.48% | -53,8 -58,1 7.33% | -37,4 -39,4 5.13% | -56,6 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -202 -97,8 -106.49% | -53,8 -59,0 8.86% | -37,4 -41,2 9.38% | -59,2 |
|
EPS USD | Released Forecast Spread | -3,24 | -10,9 -6,36 -72.15% | -1,86 -2,08 10.49% | -1,05 -1,15 9.01% | -1,32 |
| Announcement Date | 26/02/21 | 24/03/22 | 23/03/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 4,15 7,50 -44.69% | 4,97 4,07 22.21% | 7,28 2,07 251.5% | 4,46 2,03 119.54% | 8,08 3,15 156.54% | 5,90 1,59 270.65% | 1,50 1,94 -22.78% | 0,74 1,46 -49.09% | 1,46 | 1,46 | 1,46 |
|
EBITDA Million USD | Released Forecast Spread | -3,70 -11,4 67.48% | -6,71 -11,2 39.99% | -12,5 -16,6 24.8% | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -17,9 -15,2 -17.43% | -15,4 -16,2 5.35% | -15,0 -16,6 9.94% | -12,5 -15,9 21.13% | -13,2 -16,6 20.58% | -12,2 -15,6 21.4% | -6,07 -14,3 57.54% | -9,25 -14,1 34.24% | -13,0 -15,7 17.53% | -17,2 -14,2 -20.94% | -14,9 | -12,2 | -17,3 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -17,9 -16,2 -10.3% | -15,3 -15,3 -0.28% | -14,6 -16,1 9.35% | -11,9 -12,7 5.96% | -11,9 -16,3 26.81% | -12,0 -15,5 22.7% | -5,10 -13,9 63.32% | -8,29 -13,4 38.04% | -12,0 -14,0 14.47% | -16,2 -13,2 -22.88% | -13,8 | -9,79 | -15,6 |
|
Net income Million USD | Released Forecast Spread | -17,9 -15,0 -18.89% | -15,3 -16,9 9.45% | -14,6 -11,7 -24.74% | -11,9 -16,9 29.46% | -11,9 -17,2 30.81% | -12,0 -17,2 30.47% | -5,10 -14,6 64.97% | -8,29 -14,2 41.48% | -12,0 -15,9 24.39% | -16,2 -13,6 -18.97% | -14,3 | -11,4 | -16,5 |
|
EPS USD | Released Forecast Spread | -0,66 -0,53 -24.53% | -0,56 -0,62 8.94% | -0,53 -0,42 -25.2% | -0,40 -0,60 33.61% | -0,39 -0,55 28.57% | -0,34 -0,50 32% | -0,14 -0,41 65.85% | -0,23 -0,39 41.62% | -0,33 -0,43 23.96% | -0,39 -0,35 -11.43% | -0,32 | -0,23 | -0,34 |
| Announcement Date | 24/03/22 | 10/05/22 | 11/08/22 | 10/11/22 | 23/03/23 | 11/05/23 | 10/08/23 | 14/11/23 | 07/03/24 | 03/05/24 | - | - | - |
| 07/05/2024 | FORTREA HOLDINGS INC.: Q1 2024 Earnings Release |
| 07/05/2024 | VERVE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | OLEMA PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | BEAM THERAPEUTICS INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | PHARVARIS N.V.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | IDEAYA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | SANA BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 | NOVAVAX, INC.: Q1 2024 Earnings Release (Projected) |
| 07/05/2024 10:30 am | VALNEVA: Q1 2024 Earnings Release |
| 07/05/2024 04:30 pm | IONIS PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
Past sector events for Werewolf Therapeutics, Inc.
| 03/05/2024 01:40 am | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:35 am | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 03/05/2024 01:31 am | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 05:30 pm | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:35 pm | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 04:00 pm | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- HOWL Stock
- Calendar Werewolf Therapeutics, Inc.
